Search Within

Kenneth K Ng

  1. "Survivorship Research"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (8)
  2. Solid Tumor Oncology Division (8)
  3. Survivorship Research (8)
  4. Thoracic Oncology (8)
  5. Biostatistics Service (6)
  6. Epidemiology and Biostatistics (6)

More Groups

People
  1. Daphna Gelblum (5)
  2. Juliana Eng (4)
  3. Nancy Lee (4)
  4. Afsheen Iqbal (3)
  5. Andreas Rimner (3)
  6. Azadeh Namakydoust (3)

More People

Years
  1. 2022 (2)
  2. 2021 (2)
  3. 2014 (1)
  4. 2013 (1)
  5. 2002 (1)
  6. 1999 (1)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (2)
  2. Annals of Oncology (1)
  3. Cancer (1)
  4. International Journal of Cancer (1)
  5. Journal of Clinical Oncology (1)
  6. Lung Cancer (1)

More Publications

Publishers
  1. Elsevier Inc. (2)
  2. American Society of Clinical Oncology (1)
  3. Elsevier Ireland Ltd. (1)
  4. John Wiley & Sons (1)
  5. Nature Publishing Group (1)
  6. Oxford University Press (1)

More Publishers

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Any day, split halfway: Flexibility in scheduling high-dose cisplatin - A large retrospective review from a high-volume cancer center
    Journal Article

    Kang, J. J.; Tchekmedyian, V.; Mohammed, N.; Rybkin, A.; Kitpanit, S.; Fan, M.; Wang, H.; Lobaugh, S. M.; Zhang, Z.; Lee, A.; more...
    International Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)
    Journal Article

    Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S.; Smith-Marrone, S.; Mueller, B.; Ng, K. K.; Dutta, P. R.; Gelblum, D. Y.; Lee, J. L.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Phase I study of weekly albumin-bound paclitaxel (ab-P) plus weekly cetuximab (Cet) plus intensity-modulated radiation therapy (IMRT) in patients with stage III/IVb head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S. L.; Smith-Marrone, S.; Ng, K. K.; Mueller, B.; Gelblum, D. Y.; Dutta, P. R.; Lee, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis
    Journal Article

    Downey, R. J.; Ng, K. K.; Kris, M. G.; Bains, M. S.; Miller, V. A.; Heelan, R.; Bilsky, M.; Ginsberg, R.; Rusch, V. W.
    Lung Cancer (2002)

    Fulltext@MSK | Save
  • Induction chemotherapy employing dose-intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with Stage III nonsmall cell lung carcinoma
    Journal Article

    Ng, K. K.; Kris, M. G.; Ginsberg, R. J.; Heelan, R. T.; Pisters, K. M. W.; Miller, V. A.; Grant, S. C.; Bains, M.; Rusch, V.; Rosenzweig, K. E.; more...
    Cancer (1999)

    Fulltext@MSK | Save